{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:16:53Z","timestamp":1787170613464,"version":"build-2736575974"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T00:00:00Z","timestamp":1424736000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1038\/nrurol.2015.24","type":"journal-article","created":{"date-parts":[[2015,2,24]],"date-time":"2015-02-24T02:39:51Z","timestamp":1424745591000},"page":"155-166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["Risk-adapted strategy for the kidney-sparing management of upper tract tumours"],"prefix":"10.1038","volume":"12","author":[{"given":"Thomas","family":"Seisen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Colin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Roupr\u00eat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,24]]},"reference":[{"key":"BFnrurol201524_CR1","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1002\/cncr.24135","volume":"115","author":"V Margulis","year":"2009","unstructured":"Margulis, V. et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 115, 1224\u20131233 (2009).","journal-title":"Cancer"},{"key":"BFnrurol201524_CR2","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.eururo.2013.03.032","volume":"63","author":"M Roupr\u00eat","year":"2013","unstructured":"Roupr\u00eat, M. et al. European guidelines on upper tract urothelial carcinomas: 2013 update. Eur. Urol. 63, 1059\u20131071 (2013).","journal-title":"Eur. Urol."},{"key":"BFnrurol201524_CR3","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1464-410X.2007.06993.x","volume":"100","author":"G Giannarini","year":"2007","unstructured":"Giannarini, G. et al. Elective management of transitional cell carcinoma of the distal ureter: can kidney-sparing surgery be advised? BJU Int. 100, 264\u2013268 (2007).","journal-title":"BJU Int."},{"key":"BFnrurol201524_CR4","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0022-5347(05)67135-2","volume":"164","author":"GL Chen","year":"2000","unstructured":"Chen, G. L. & Bagley, D. H. Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. J. Urol. 164, 1173\u20131176 (2000).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/01.ju.0000132128.79974.db","volume":"172","author":"J Palou","year":"2004","unstructured":"Palou, J. et al. Percutaneous nephroscopic management of upper urinary tract transitional cell carcinoma: recurrence and long-term followup. J. Urol. 172, 66\u201369 (2004).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.eururo.2012.10.020","volume":"63","author":"P Colin","year":"2013","unstructured":"Colin, P. et al. Conservative management of upper tract urothelial carcinoma in France: a 2004\u20132011 national practice report. Eur. Urol. 63, 405\u2013406 (2013).","journal-title":"Eur. Urol."},{"key":"BFnrurol201524_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.eururo.2013.12.007","volume":"66","author":"M Roupr\u00eat","year":"2013","unstructured":"Roupr\u00eat, M., Colin, P. & Yates, D. R. A new proposal to risk stratify urothelial carcinomas of the upper urinary tract (UTUCs) in a predefinitive treatment setting: low-risk versus high-risk UTUCs. Eur. Urol. 66, 181\u2013183 (2013).","journal-title":"Eur. Urol."},{"key":"BFnrurol201524_CR8","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/j.1464-410X.2011.10363.x","volume":"109","author":"F Audenet","year":"2012","unstructured":"Audenet, F., Traxer, O., Yates, D. R., Cussenot, O. & Roupr\u00eat, M. Potential role of photodynamic techniques combined with new generation flexible ureterorenoscopes and molecular markers for the management of urothelial carcinoma of the upper urinary tract. BJU Int. 109, 608\u2013613 (2012).","journal-title":"BJU Int."},{"key":"BFnrurol201524_CR9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1089\/end.2008.0251","volume":"23","author":"RW Pak","year":"2009","unstructured":"Pak, R. W., Moskowitz, E. J. & Bagley, D. H. What is the cost of maintaining a kidney in upper-tract transitional-cell carcinoma? An objective analysis of cost and survival. J. Endourol. 23, 341\u2013346 (2009).","journal-title":"J. Endourol."},{"key":"BFnrurol201524_CR10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s00345-012-0949-3","volume":"31","author":"F Audenet","year":"2013","unstructured":"Audenet, F., Traxer, O., Bensalah, K. & Roupr\u00eat, M. Upper urinary tract instillations in the treatment of urothelial carcinomas: a review of technical constraints and outcomes. World J. Urol. 31, 45\u201352 (2013).","journal-title":"World J. Urol."},{"key":"BFnrurol201524_CR11","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.urolonc.2011.12.021","volume":"31","author":"J Straub","year":"2013","unstructured":"Straub, J., Strittmatter, F., Karl, A., Stief, C. G. & Tritschler, S. Ureterorenoscopic biopsy and urinary cytology according to the 2004 WHO classification underestimate tumor grading in upper urinary tract urothelial carcinoma. Urol. Oncol. 31, 1166\u20131170 (2013).","journal-title":"Urol. Oncol."},{"key":"BFnrurol201524_CR12","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0090-4295(03)00026-8","volume":"61","author":"A Skolarikos","year":"2003","unstructured":"Skolarikos, A. et al. Cytologic analysis of ureteral washings is informative in patients with grade 2 upper tract TCC considering endoscopic treatment. Urology 61, 1146\u20131150 (2003).","journal-title":"Urology"},{"key":"BFnrurol201524_CR13","doi-asserted-by":"publisher","first-page":"400","DOI":"10.5858\/arpa.2012-0136-OA","volume":"137","author":"V Vashistha","year":"2013","unstructured":"Vashistha, V., Shabsigh, A. & Zynger, D. L. Utility and diagnostic accuracy of ureteroscopic biopsy in upper tract urothelial carcinoma. Arch. Pathol. Lab. Med. 137, 400\u2013407 (2013).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"BFnrurol201524_CR14","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1097\/PAS.0b013e3181aec42a","volume":"33","author":"F Tavora","year":"2009","unstructured":"Tavora, F. et al. Small endoscopic biopsies of the ureter and renal pelvis: pathologic pitfalls. Am. J. Surg. Pathol. 33, 1540\u20131546 (2009).","journal-title":"Am. J. Surg. Pathol."},{"key":"BFnrurol201524_CR15","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1089\/end.2013.0220","volume":"27","author":"N Kleinmann","year":"2013","unstructured":"Kleinmann, N. et al. Ureteroscopic biopsy of upper tract urothelial carcinoma: comparison of basket and forceps. J. Endourol. 27, 1450\u20131454 (2013).","journal-title":"J. Endourol."},{"key":"BFnrurol201524_CR16","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000354875","volume":"93","author":"SM Al-Qahtani","year":"2014","unstructured":"Al-Qahtani, S. M., Legraverend, D., Gil-Diez de Medina, S., Sibony, M. & Traxer, O. Can we improve the biopsy quality of upper urinary tract urothelial tumors? Single-center preliminary results of a new biopsy forceps. Urol. Int. 93, 34\u201337 (2014).","journal-title":"Urol. Int."},{"key":"BFnrurol201524_CR17","volume-title":"TNM Classification of Malignant Tumours","author":"LH Sobin","year":"2009","unstructured":"Sobin, L. H. et al. (eds) TNM Classification of Malignant Tumours, 7th edn (Wiley-Blackwell, 2009)."},{"key":"BFnrurol201524_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.pdpdt.2009.12.005","volume":"7","author":"BK Somani","year":"2010","unstructured":"Somani, B. K., Moseley, H., Eljamel, M. S., Nabi, G. & Kata, S. G. Photodynamic diagnosis (PDD) for upper urinary tract transitional cell carcinoma (UT-TCC): evolution of a new technique. Photodiagnosis Photodyn. Ther. 7, 39\u201343 (2010).","journal-title":"Photodyn. Ther."},{"key":"BFnrurol201524_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1089\/end.2009.0593","volume":"25","author":"O Traxer","year":"2011","unstructured":"Traxer, O., Geavlete, B., de Medina, S. G. D., Sibony, M. & Al-Qahtani, S. M. Narrow-band imaging digital flexible ureteroscopy in detection of upper urinary tract transitional-cell carcinoma: initial experience. J. Endourol. 25, 19\u201323 (2011).","journal-title":"J. Endourol."},{"key":"BFnrurol201524_CR20","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/j.juro.2013.08.006","volume":"190","author":"MTJ Bus","year":"2013","unstructured":"Bus, M. T. J. et al. Volumetric in vivo visualization of upper urinary tract tumors using optical coherence tomography: a pilot study. J. Urol. 190, 2236\u20132242 (2013).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR21","first-page":"1653","volume-title":"Campbell-Walsh Urology","author":"A Sagalowsky","year":"2007","unstructured":"Sagalowsky, A. & Jarret, T. in Campbell-Walsh Urology, 9th edn (eds Wein, A. J. et al.) 1653\u20131685 (Saunders Elsevier, 2007)."},{"key":"BFnrurol201524_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.urology.2006.10.014","volume":"69","author":"T Kondo","year":"2007","unstructured":"Kondo, T. et al. Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract. Urology 69, 265\u2013269 (2007).","journal-title":"Urology"},{"key":"BFnrurol201524_CR23","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0022-5347(17)49735-7","volume":"132","author":"F Pagano","year":"1984","unstructured":"Pagano, F. Conservative treatment of lower ureteral tumor: modified ureteroneocystostomy for upper urinary tract endoscopic control. J. Urol. 132, 555\u2013557 (1984).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR24","doi-asserted-by":"publisher","first-page":"E744","DOI":"10.1111\/j.1464-410X.2012.11554.x","volume":"110","author":"A Simonato","year":"2012","unstructured":"Simonato, A. et al. Elective segmental ureterectomy for transitional cell carcinoma of the ureter: long-term follow-up in a series of 73 patients. BJU Int. 110, E744\u2013749 (2012).","journal-title":"BJU Int."},{"key":"BFnrurol201524_CR25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1159\/000209368","volume":"82","author":"D Dragicevic","year":"2009","unstructured":"Dragicevic, D. et al. Comparison of open nephroureterectomy and open conservative management of upper urinary tract transitional cell carcinoma. Urol. Int. 82, 335\u2013340 (2009).","journal-title":"Urol. Int."},{"key":"BFnrurol201524_CR26","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.juro.2009.12.018","volume":"183","author":"C Jeldres","year":"2010","unstructured":"Jeldres, C. et al. Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter. J. Urol. 183, 1324\u20131329 (2010).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR27","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/j.1464-410X.2012.10960.x","volume":"110","author":"P Colin","year":"2012","unstructured":"Colin, P. et al. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study. BJU Int. 110, 1134\u20131141 (2012).","journal-title":"BJU Int."},{"key":"BFnrurol201524_CR28","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.urology.2012.12.059","volume":"81","author":"A Bagrodia","year":"2013","unstructured":"Bagrodia, A. et al. Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma. Urology 81, 972\u2013977 (2013).","journal-title":"Urology"},{"key":"BFnrurol201524_CR29","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s11255-013-0514-z","volume":"46","author":"SY Hung","year":"2014","unstructured":"Hung, S. Y. et al. Segmental ureterectomy does not compromise the oncologic outcome compared with nephroureterectomy for pure ureter cancer. Int. Urol. Nephrol. 46, 921\u2013926 (2014).","journal-title":"Int. Urol. Nephrol."},{"key":"BFnrurol201524_CR30","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.urolonc.2013.01.001","volume":"32","author":"O Dalpiaz","year":"2014","unstructured":"Dalpiaz, O., Ehrlich, G., Quehenberger, F., Pummer, K. & Zigeuner, R. Distal ureterectomy is a safe surgical option in patients with urothelial carcinoma of the distal ureter. Urol. Oncol. 32, e1\u2013e8 (2014).","journal-title":"Urol. Oncol."},{"key":"BFnrurol201524_CR31","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1111\/iju.12554","volume":"21","author":"H Fukushima","year":"2014","unstructured":"Fukushima, H. et al. Equivalent survival and improved preservation of renal function after distal ureterectomy compared with nephroureterectomy in patients with urothelial carcinoma of the distal ureter: A propensity score-matched multicenter study. Int. J. Urol. 21, 1098\u20131104 (2014).","journal-title":"Int. J. Urol."},{"key":"BFnrurol201524_CR32","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.juro.2011.09.150","volume":"187","author":"JL Silberstein","year":"2012","unstructured":"Silberstein, J. L. et al. Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma. J. Urol. 187, 429\u2013434 (2012).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR33","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/S0022-5347(17)36277-8","volume":"149","author":"PS Chandhoke","year":"1993","unstructured":"Chandhoke, P. S. et al. Laparoscopic ureterectomy: initial clinical experience. J. Urol. 149, 992\u2013997 (1993).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR34","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1464-410X.2006.06688.x","volume":"99","author":"M Roupr\u00eat","year":"2007","unstructured":"Roupr\u00eat, M. et al. Laparoscopic distal ureterectomy and anastomosis for management of low-risk upper urinary tract transitional cell carcinoma: preliminary results. BJU Int. 99, 623\u2013627 (2007).","journal-title":"BJU Int."},{"key":"BFnrurol201524_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1089\/end.2007.0279","volume":"23","author":"M Glinianski","year":"2009","unstructured":"Glinianski, M., Guru, K. A., Zimmerman, G., Mohler, J. & Kim, H. L. Robot-assisted ureterectomy and ureteral reconstruction for urothelial carcinoma. J. Endourol. 23, 97\u2013100 (2009).","journal-title":"J. Endourol."},{"key":"BFnrurol201524_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1089\/lap.2009.0269","volume":"20","author":"S Allaparthi","year":"2010","unstructured":"Allaparthi, S., Ramanathan, R. & Balaji, K. C. Robotic distal ureterectomy with boari flap reconstruction for distal ureteral urothelial cancers: a single institutional pilot experience. J. Laparoendosc. Adv. Surg. Tech. A 20, 165\u2013171 (2010).","journal-title":"J. Laparoendosc. Adv. Surg. Tech. A"},{"key":"BFnrurol201524_CR37","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/S0090-4295(99)00121-1","volume":"54","author":"M Grasso","year":"1999","unstructured":"Grasso, M., Fraiman, M. & Levine, M. Ureteropyeloscopic diagnosis and treatment of upper urinary tract urothelial malignancies. Urology 54, 240\u2013246 (1999).","journal-title":"Urology"},{"key":"BFnrurol201524_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.eururo.2008.12.012","volume":"56","author":"MJ Bader","year":"2009","unstructured":"Bader, M. J. et al. Laser therapy for upper urinary tract transitional cell carcinoma: indications and management. Eur. Urol. 56, 65\u201371 (2009).","journal-title":"Eur. Urol."},{"key":"BFnrurol201524_CR39","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/S0022-5347(17)41027-5","volume":"141","author":"NT Schmeller","year":"1989","unstructured":"Schmeller, N. T. & Hofstetter, A. G. Laser treatment of ureteral tumors. J. Urol. 141, 840\u2013843 (1989).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3109\/00365599409180492","volume":"28","author":"JR Andersen","year":"1994","unstructured":"Andersen, J. R. & Kristensen, J. K. Ureteroscopic management of transitional cell tumors. Scand. J. Urol. Nephrol. 28, 153\u2013157 (1994).","journal-title":"Scand. J. Urol. Nephrol."},{"key":"BFnrurol201524_CR41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1089\/end.1994.8.37","volume":"8","author":"F Gaboardi","year":"1994","unstructured":"Gaboardi, F., Bozzola, A., Dotti, E. & Galli, L. Conservative treatment of upper urinary tract tumors with Nd:YAG laser. J. Endourol. 8, 37\u201341 (1994).","journal-title":"J. Endourol."},{"key":"BFnrurol201524_CR42","first-page":"113","volume":"2","author":"EI Engelmyer","year":"1996","unstructured":"Engelmyer, E. I. & Belis, J. A. Long-term ureteroscopic management of low-grade transitional cell carcinoma of the upper urinary tract. Tech. Urol. 2, 113\u2013116 (1996).","journal-title":"Tech. Urol."},{"key":"BFnrurol201524_CR43","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/cncr.11446","volume":"98","author":"S Daneshmand","year":"2003","unstructured":"Daneshmand, S., Quek, M. L. & Huffman, J. L. Endoscopic management of upper urinary tract transitional cell carcinoma: long-term experience. Cancer 98, 55\u201360 (2003).","journal-title":"Cancer"},{"key":"BFnrurol201524_CR44","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/lsm.10184","volume":"32","author":"K Matsuoka","year":"2003","unstructured":"Matsuoka, K., Lida, S., Tomiyasu, K., Inoue, M. & Noda, S. Transurethral endoscopic treatment of upper urinary tract tumors using a holmium:YAG laser. Lasers Surg. Med. 32, 336\u2013340 (2003).","journal-title":"Lasers Surg. Med."},{"key":"BFnrurol201524_CR45","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/S0022-5347(05)64041-4","volume":"169","author":"I Iborra","year":"2003","unstructured":"Iborra, I. et al. Conservative elective treatment of upper urinary tract tumors: a multivariate analysis of prognostic factors for recurrence and progression. J. Urol. 169, 82\u201385 (2003).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR46","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/01.mou.0000160622.13366.a1","volume":"15","author":"GB Johnson","year":"2005","unstructured":"Johnson, G. B. & Grasso, M. Ureteroscopic management of upper urinary tract transitional cell carcinoma. Curr. Opin. Urol. 15, 89\u201393 (2005).","journal-title":"Curr. Opin. Urol."},{"key":"BFnrurol201524_CR47","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.urology.2005.12.034","volume":"67","author":"M Roupr\u00eat","year":"2006","unstructured":"Roupr\u00eat, M. et al. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma. Urology 67, 1181\u20131187 (2006).","journal-title":"Urology"},{"key":"BFnrurol201524_CR48","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.urology.2007.03.065","volume":"70","author":"K Reisiger","year":"2007","unstructured":"Reisiger, K., Hruby, G., Clayman, R. V. & Landman, J. Office-based surveillance ureteroscopy after endoscopic treatment of transitional cell carcinoma: technique and clinical outcome. Urology 70, 263\u2013266 (2007).","journal-title":"Urology"},{"key":"BFnrurol201524_CR49","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.juro.2007.01.006","volume":"177","author":"AE Krambeck","year":"2007","unstructured":"Krambeck, A. E. et al. Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma. J. Urol. 177, 1721\u20131726 (2007).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR50","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1089\/end.2008.0187","volume":"22","author":"DJ Painter","year":"2008","unstructured":"Painter, D. J., Denton, K., Timoney, A. G. & Keeley, F. X. Ureteroscopic management of upper-tract urothelial cancer: an exciting nephron-sparing option or an unacceptable risk? J. Endourol. 22, 1237\u20131239 (2008).","journal-title":"J. Endourol."},{"key":"BFnrurol201524_CR51","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/j.1464-410X.2008.07535.x","volume":"102","author":"SM Lucas","year":"2008","unstructured":"Lucas, S. M. et al. Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery. BJU Int. 102, 172\u2013176 (2008).","journal-title":"BJU Int."},{"key":"BFnrurol201524_CR52","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00345-009-0494-x","volume":"28","author":"J-N Cornu","year":"2010","unstructured":"Cornu, J.-N. et al. Oncologic control obtained after exclusive flexible ureteroscopic management of upper urinary tract urothelial cell carcinoma. World J. Urol. 28, 151\u2013156 (2010).","journal-title":"World J. Urol."},{"key":"BFnrurol201524_CR53","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1016\/j.juro.2010.02.005","volume":"183","author":"AJ Gadzinski","year":"2010","unstructured":"Gadzinski, A. J., Roberts, W. W., Faerber, G. J. & Wolf, J. S. Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma. J. Urol. 183, 2148\u20132153 (2010).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR54","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1111\/j.1464-410X.2012.11169.x","volume":"110","author":"ML Cutress","year":"2012","unstructured":"Cutress, M. L. et al. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience. BJU Int. 110, 1608\u20131617 (2012).","journal-title":"BJU Int."},{"key":"BFnrurol201524_CR55","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1111\/j.1464-410X.2012.11066.x","volume":"110","author":"M Grasso","year":"2012","unstructured":"Grasso, M., Fishman, A. I., Cohen, J. & Alexander, B. Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients. BJU Int. 110, 1618\u20131626 (2012).","journal-title":"BJU Int."},{"key":"BFnrurol201524_CR56","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00345-012-0948-4","volume":"31","author":"H Fajkovic","year":"2013","unstructured":"Fajkovic, H. et al. Results and outcomes after endoscopic treatment of upper urinary tract carcinoma: the Austrian experience. World J. Urol. 31, 37\u201344 (2013).","journal-title":"World J. Urol."},{"key":"BFnrurol201524_CR57","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/j.1464-410X.2012.11068.x","volume":"110","author":"ML Cutress","year":"2012","unstructured":"Cutress, M. L. et al. Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review. BJU Int. 110, 614\u2013628 (2012).","journal-title":"BJU Int."},{"key":"BFnrurol201524_CR58","doi-asserted-by":"publisher","first-page":"426","DOI":"10.4111\/kju.2013.54.7.426","volume":"54","author":"BH Park","year":"2013","unstructured":"Park, B. H. & Jeon, S. S. Endoscopic management of upper urinary tract urothelial carcinoma. Korean J. Urol. 54, 426\u2013432 (2013).","journal-title":"Korean J. Urol."},{"key":"BFnrurol201524_CR59","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/S0022-5347(17)40130-3","volume":"143","author":"A Tasca","year":"1990","unstructured":"Tasca, A. & Zattoni, F. The case for a percutaneous approach to transitional cell carcinoma of the renal pelvis. J. Urol. 143, 902\u2013904 (1990).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR60","first-page":"15","volume":"172","author":"S Fuglsig","year":"1995","unstructured":"Fuglsig, S. & Krarup, T. Percutaneous nephroscopic resection of renal pelvic tumors. Scand. J. Urol. Nephrol. Suppl. 172, 15\u201317 (1995).","journal-title":"Scand. J. Urol. Nephrol. Suppl."},{"key":"BFnrurol201524_CR61","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/j.1464-410X.1995.tb07382.x","volume":"75","author":"HR Plancke","year":"1995","unstructured":"Plancke, H. R., Strijbos, W. E. & Delaere, K. P. Percutaneous endoscopic treatment of urothelial tumours of the renal pelvis. Br. J. Urol. 75, 736\u2013739 (1995).","journal-title":"Br. J. Urol."},{"key":"BFnrurol201524_CR62","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/S0022-5347(01)66330-4","volume":"155","author":"A Patel","year":"1996","unstructured":"Patel, A. et al. Long-term outcome after percutaneous treatment of transitional cell carcinoma of the renal pelvis. J. Urol. 155, 868\u2013874 (1996).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR63","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/S0022-5347(01)61765-8","volume":"161","author":"PE Clark","year":"1999","unstructured":"Clark, P. E., Streem, S. B. & Geisinger, M. A. 13-year experience with percutaneous management of upper tract transitional cell carcinoma. J. Urol. 161, 772\u2013775 (1999).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR64","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1097\/01.ju.0000050242.68745.4d","volume":"169","author":"MC Goel","year":"2003","unstructured":"Goel, M. C., Mahendra, V. & Roberts, J. G. Percutaneous management of renal pelvic urothelial tumors: long-term followup. J. Urol. 169, 925\u2013929 (2003).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR65","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.eururo.2006.07.019","volume":"51","author":"M Roupr\u00eat","year":"2007","unstructured":"Roupr\u00eat, M. et al. Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection. Eur. Urol. 51, 709\u2013713 (2007).","journal-title":"Eur. Urol."},{"key":"BFnrurol201524_CR66","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.urology.2008.06.026","volume":"73","author":"AR Rastinehad","year":"2009","unstructured":"Rastinehad, A. R. et al. A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Gu\u00e9rin therapy? Urology 73, 27\u201331 (2009).","journal-title":"Urology"},{"key":"BFnrurol201524_CR67","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S0022-5347(01)67632-8","volume":"153","author":"A Huang","year":"1995","unstructured":"Huang, A., Low, R. K. & deVere White, R. Nephrostomy tract tumor seeding following percutaneous manipulation of a ureteral carcinoma. J. Urol. 153, 1041\u20131042 (1995).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR68","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.eururo.2004.01.021","volume":"46","author":"C Treuthardt","year":"2004","unstructured":"Treuthardt, C., Danuser, H. & Studer, U. E. Tumor seeding following percutaneous antegrade treatment of transitional cell carcinoma in the renal pelvis. Eur. Urol. 46, 442\u2013443 (2004).","journal-title":"Eur. Urol."},{"key":"BFnrurol201524_CR69","first-page":"819470","volume":"2013","author":"I Sorokin","year":"2013","unstructured":"Sorokin, I., Welliver, R. C., Elkadi, O., Nazeer, T. & Kaufman, R. P. Tumor seeding of percutaneous nephrostomy tract from urothelial carcinoma of the kidney. Case Rep. Urol. 2013, 819470 (2013).","journal-title":"Case Rep. Urol."},{"key":"BFnrurol201524_CR70","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S0022-5347(01)65854-3","volume":"156","author":"JA Mart\u00ednez-Pi\u00f1eiro","year":"1996","unstructured":"Mart\u00ednez-Pi\u00f1eiro, J. A., Garc\u00eda Matres, M. J. & Mart\u00ednez-Pi\u00f1eiro, L. Endourological treatment of upper tract urothelial carcinomas: analysis of a series of 59 tumors. J. Urol. 156, 377\u2013385 (1996).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR71","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0302-2838(02)00220-8","volume":"42","author":"E Deligne","year":"2002","unstructured":"Deligne, E. et al. Conservative management of upper urinary tract tumors. Eur. Urol. 42, 43\u201348 (2002).","journal-title":"Eur. Urol."},{"key":"BFnrurol201524_CR72","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1097\/01.ju.0000097327.20188.c1","volume":"170","author":"RS Suh","year":"2003","unstructured":"Suh, R. S., Faerber, G. J. & Wolf, J. S. Predictive factors for applicability and success with endoscopic treatment of upper tract urothelial carcinoma. J. Urol. 170, 2209\u20132216 (2003).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR73","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.urology.2007.11.018","volume":"71","author":"RH Thompson","year":"2008","unstructured":"Thompson, R. H. et al. Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. Urology 71, 713\u2013717 (2008).","journal-title":"Urology"},{"key":"BFnrurol201524_CR74","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1089\/end.2010.0276","volume":"25","author":"EM Raymundo","year":"2011","unstructured":"Raymundo, E. M. et al. Third prize: the role of endoscopic nephron-sparing surgery in the management of upper tract urothelial carcinoma. J. Endourol. 25, 377\u2013384 (2011).","journal-title":"J. Endourol."},{"key":"BFnrurol201524_CR75","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.juro.2012.12.006","volume":"189","author":"ML Cutress","year":"2013","unstructured":"Cutress, M. L. et al. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience. J. Urol. 189, 2054\u20132060 (2013).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR76","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1471-2490-14-97","volume":"14","author":"A Hoffman","year":"2014","unstructured":"Hoffman, A., Yossepowitch, O., Erlich, Y., Holland, R. & Lifshitz, D. Oncologic results of Nephron sparing endoscopic approach for upper tract low grade transitional cell carcinoma in comparison to nephroureterectomy\u2014a case control study. BMC Urol. 14, 97 (2014).","journal-title":"BMC Urol."},{"key":"BFnrurol201524_CR77","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.ejso.2014.06.007","volume":"40","author":"R Yakoubi","year":"2014","unstructured":"Yakoubi, R. et al. Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studies. Eur. J. Surg. Oncol. 40, 1629\u20131634 (2014).","journal-title":"Eur. J. Surg. Oncol."},{"key":"BFnrurol201524_CR78","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/bju.12341","volume":"114","author":"J Simhan","year":"2014","unstructured":"Simhan, J. et al. Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma. BJU Int. 114, 216\u2013220 (2014).","journal-title":"BJU Int."},{"key":"BFnrurol201524_CR79","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0302-2838(03)00040-X","volume":"43","author":"M Miladi","year":"2003","unstructured":"Miladi, M., Peyromaure, M., Zerbib, M., Sa\u00efghi, D. & Debr\u00e9, B. The value of a second transurethral resection in evaluating patients with bladder tumours. Eur. Urol. 43, 241\u2013245 (2003).","journal-title":"Eur. Urol."},{"key":"BFnrurol201524_CR80","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.eururo.2010.03.007","volume":"58","author":"RT Divrik","year":"2010","unstructured":"Divrik, R. T., Sahin, A. F., Yildirim, U., Altok, M. & Zorlu, F. Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial. Eur. Urol. 58, 185\u2013190 (2010).","journal-title":"Eur. Urol."},{"key":"BFnrurol201524_CR81","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.eururo.2013.06.003","volume":"64","author":"M Babjuk","year":"2013","unstructured":"Babjuk, M. et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur. Urol. 64, 639\u2013653 (2013).","journal-title":"Eur. Urol."},{"key":"BFnrurol201524_CR82","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1016\/S1569-9056(14)60027-0","volume":"13","author":"D Lifshitz","year":"2014","unstructured":"Lifshitz, D., Melron, M., Kinirty, M. & Schoenberg M. Hydrogel based drug retention system for the treatment of upper tract urothelial carcinoma. EAU 2014. Eur. Urol. Suppl. 13, e26 (2014).","journal-title":"Eur. Urol. Suppl."},{"key":"BFnrurol201524_CR83","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/S0022-5347(01)66732-6","volume":"154","author":"TW Jarrett","year":"1995","unstructured":"Jarrett, T. W., Sweetser, P. M., Weiss, G. H. & Smith, A. D. Percutaneous management of transitional cell carcinoma of the renal collecting system: 9-year experience. J. Urol. 154, 1629\u20131635 (1995).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR84","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4103\/0974-7796.115746","volume":"5","author":"OM Aboumarzouk","year":"2013","unstructured":"Aboumarzouk, O. M. et al. Mitomycin C instillation following ureterorenoscopic laser ablation of upper urinary tract carcinoma. Urol. Ann. 5, 184\u2013189 (2013).","journal-title":"Urol. Ann."},{"key":"BFnrurol201524_CR85","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0022-5347(17)36117-7","volume":"149","author":"JR Sharpe","year":"1993","unstructured":"Sharpe, J. R., Duffy, G. & Chin, J. L. Intrarenal bacillus Calmette-Guerin therapy for upper urinary tract carcinoma in situ. J. Urol. 149, 457\u2013459 (1993).","journal-title":"in situ. J. Urol."},{"key":"BFnrurol201524_CR86","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1046\/j.1464-410X.1996.09559.x","volume":"77","author":"H Yokogi","year":"1996","unstructured":"Yokogi, H., Wada, Y., Mizutani, M., Igawa, M. & Ishibe, T. Bacillus Calmette-Gu\u00e9rin perfusion therapy for carcinoma in situ of the upper urinary tract. Br. J. Urol. 77, 676\u2013679 (1996).","journal-title":"Br. J. Urol."},{"key":"BFnrurol201524_CR87","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1046\/j.1464-410x.2000.00610.x","volume":"85","author":"Y Nishino","year":"2000","unstructured":"Nishino, Y., Yamamoto, N., Komeda, H., Takahashi, Y. & Deguchi, T. Bacillus Calmette-Gu\u00e9rin instillation treatment for carcinoma in situ of the upper urinary tract. BJU Int. 85, 799\u2013801 (2000).","journal-title":"BJU Int."},{"key":"BFnrurol201524_CR88","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1159\/000020365","volume":"38","author":"N Nonomura","year":"2000","unstructured":"Nonomura, N. et al. Bacillus Calmette-Gu\u00e9rin perfusion therapy for the treatment of transitional cell carcinoma in situ of the upper urinary tract. Eur. Urol. 38, 701\u2013704 (2000).","journal-title":"Eur. Urol."},{"key":"BFnrurol201524_CR89","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1046\/j.1464-410X.2001.02297.x","volume":"88","author":"K Okubo","year":"2001","unstructured":"Okubo, K. et al. Intrarenal bacillus Calmette-Gu\u00e9rin therapy for carcinoma in situ of the upper urinary tract: long-term follow-up and natural course in cases of failure. BJU Int. 88, 343\u2013347 (2001).","journal-title":"BJU Int."},{"key":"BFnrurol201524_CR90","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/S0022-5347(05)64454-0","volume":"168","author":"GN Thalmann","year":"2002","unstructured":"Thalmann, G. N., Markwalder, R., Walter, B. & Studer, U. E. Long-term experience with bacillus Calmette-Guerin therapy of upper urinary tract transitional cell carcinoma in patients not eligible for surgery. J. Urol. 168, 1381\u20131385 (2002).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR91","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0090-4295(01)01488-1","volume":"59","author":"A Irie","year":"2002","unstructured":"Irie, A. et al. Intravesical instillation of bacille Calmette-Gu\u00e9rin for carcinoma in situ of the urothelium involving the upper urinary tract using vesicoureteral reflux created by a double-pigtail catheter. Urology 59, 53\u201357 (2002).","journal-title":"Urology"},{"key":"BFnrurol201524_CR92","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1046\/j.1442-2042.2002.00551.x","volume":"9","author":"H Miyake","year":"2002","unstructured":"Miyake, H. et al. Clinical outcome of bacillus Calmette-Gu\u00e9rin perfusion therapy for carcinoma in situ of the upper urinary tract. Int. J. Urol. 9, 677\u2013680 (2002).","journal-title":"Int. J. Urol."},{"key":"BFnrurol201524_CR93","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.urology.2004.01.046","volume":"63","author":"Y Hayashida","year":"2004","unstructured":"Hayashida, Y. et al. Long-term effects of bacille Calmette-Gu\u00e9rin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract. Urology 63, 1084\u20131088 (2004).","journal-title":"Urology"},{"key":"BFnrurol201524_CR94","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1442-2042.2006.01312.x","volume":"13","author":"Y Kojima","year":"2006","unstructured":"Kojima, Y. et al. Long-term outcome of upper urinary tract carcinoma in situ: effectiveness of nephroureterectomy versus bacillus Calmette-Gu\u00e9rin therapy. Int. J. Urol. 13, 340\u2013344 (2006).","journal-title":"Int. J. Urol."},{"key":"BFnrurol201524_CR95","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.eururo.2011.07.051","volume":"60","author":"G Giannarini","year":"2011","unstructured":"Giannarini, G., Kessler, T. M., Birkh\u00e4user, F. D., Thalmann, G. N. & Studer, U. E. Antegrade perfusion with bacillus Calmette-Gu\u00e9rin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit? Eur. Urol. 60, 955\u2013960 (2011).","journal-title":"Eur. Urol."},{"key":"BFnrurol201524_CR96","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S0022-5347(17)44272-8","volume":"137","author":"AD Smith","year":"1987","unstructured":"Smith, A. D., Orihuela, E. & Crowley, A. R. Percutaneous management of renal pelvic tumors: a treatment option in selected cases. J. Urol. 137, 852\u2013856 (1987).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR97","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0094-0143(21)01586-X","volume":"15","author":"E Orihuela","year":"1988","unstructured":"Orihuela, E. & Smith, A. D. Percutaneous treatment of transitional cell carcinoma of the upper urinary tract. Urol. Clin. North Am. 15, 425\u2013431 (1988).","journal-title":"Urol. Clin. North Am."},{"key":"BFnrurol201524_CR98","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/S0022-5347(17)37897-7","volume":"146","author":"MP Schoenberg","year":"1991","unstructured":"Schoenberg, M. P., Van Arsdalen, K. N. & Wein, A. J. The management of transitional cell carcinoma in solitary renal units. J. Urol. 146, 700\u2013702 (1991).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR99","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/S0022-5347(17)35473-3","volume":"150","author":"JA Eastham","year":"1993","unstructured":"Eastham, J. A. & Huffman, J. L. Technique of mitomycin C instillation in the treatment of upper urinary tract urothelial tumors. J. Urol. 150, 324\u2013325 (1993).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR100","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S0090-4295(99)80005-3","volume":"45","author":"SP Vasavada","year":"1995","unstructured":"Vasavada, S. P., Streem, S. B. & Novick, A. C. Definitive tumor resection and percutaneous bacille Calmette-Gu\u00e9rin for management of renal pelvic transitional cell carcinoma in solitary kidneys. Urology 45, 381\u2013386 (1995).","journal-title":"Urology"},{"key":"BFnrurol201524_CR101","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0022-5347(01)64015-1","volume":"159","author":"A Patel","year":"1998","unstructured":"Patel, A. & Fuchs, G. J. New techniques for the administration of topical adjuvant therapy after endoscopic ablation of upper urinary tract transitional cell carcinoma. J. Urol. 159, 71\u201375 (1998).","journal-title":"J. Urol."},{"key":"BFnrurol201524_CR102","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0094-0143(05)70122-1","volume":"27","author":"ME Jabbour","year":"2000","unstructured":"Jabbour, M. E. & Smith, A. D. Primary percutaneous approach to upper urinary tract transitional cell carcinoma. Urol. Clin. North Am. 27, 739\u2013750 (2000).","journal-title":"Urol. Clin. North Am."},{"key":"BFnrurol201524_CR103","doi-asserted-by":"publisher","unstructured":"Seisen, T. et al. A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma. Eur. Urol. http:\/\/dx.doi.org\/10.1016\/j.eururo.2014.11.035 (2014).","DOI":"10.1016\/j.eururo.2014.11.035"},{"key":"BFnrurol201524_CR104","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.eururo.2011.05.064","volume":"60","author":"T O'Brien","year":"2011","unstructured":"O'Brien, T. et al. Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial). Eur. Urol. 60, 703\u2013710 (2011).","journal-title":"Eur. Urol."},{"key":"BFnrurol201524_CR105","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1200\/JCO.2012.45.2128","volume":"31","author":"A Ito","year":"2013","unstructured":"Ito, A. et al. Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial. J. Clin. Oncol. 31, 1422\u20131427 (2013).","journal-title":"J. Clin. Oncol."},{"key":"BFnrurol201524_CR106","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1464-410X.2010.09899.x","volume":"108","author":"J Messer","year":"2011","unstructured":"Messer, J. et al. Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. BJU Int. 108, 701\u2013705 (2011).","journal-title":"BJU Int."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2015.24.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2015.24","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2015.24.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T07:03:26Z","timestamp":1717743806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrurol.2015.24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,24]]},"references-count":106,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["BFnrurol201524"],"URL":"https:\/\/doi.org\/10.1038\/nrurol.2015.24","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,24]]},"assertion":[{"value":"24 February 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}